FDA on PROMs. Two important points.
Rowen D, Carlton J, Brazier JE, Mulhern B, Palfreyman S, Stevens K, Tsuchiya A.
Rowen D, et al. Among authors: carlton j.
BMJ. 2010 Oct 5;341:c5454. doi: 10.1136/bmj.c5454.
BMJ. 2010.
PMID: 20923843
No abstract available.